We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVCS.L Regulatory News (PVCS)

  • There is currently no data for PVCS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Aug 2015 07:01

RNS Number : 2201X
PV Crystalox Solar PLC
27 August 2015
 



PV Crystalox Solar PLC

Interim results to 30 June 2015

 

PV Crystalox Solar PLC (the "Group"), a long established supplier of photovoltaic ("PV") silicon wafers, today announces its interim results for the six months ended 30 June 2015.

 

Highlights

· Group continues to limit output to conserve cash

· Wafer shipments were104MW (H1 2014: 99MW)

· Request for ICC arbitration filed to resolve dispute with LT wafer contract customer

· Major polysilicon contract expires at end of 2015

 

Financial Overview

· Revenues €33.4m (H1 2014: €30.1m)

· Loss before taxes (EBT) €(9.5)m (H1 2014: €(6.9)m)

· Net cash €17.1m (31 December 2014: €24.6m)

· Inventories €28.0m (31 December 2014: €28.6m)

 

Iain Dorrity, Chief Executive Officer, commented:

 "The adverse market conditions which have existed since 2011 are expected to continue in the short term and the recent devaluation of the Chinese currency is likely to intensify pressure on pricing. In view of the challenging environment and mindful of the need to protect shareholder value, the Board plans to complete a strategic review of the business before the end of the year."

 

 Enquiries:

PV Crystalox Solar PLC +44 (0) 1235 437160

Iain Dorrity, Chief Executive Officer

Matthew Wethey, Chief Financial Officer and Group Secretary

About PV Crystalox Solar PLC

PV Crystalox Solar is a long established supplier to the global photovoltaic industry, producing multicrystalline silicon wafers for use in solar electricity generation systems.

Chairman and Chief Executive's joint statement

 

Overview and strategic update

The global photovoltaic industry environment has deteriorated further during 2015 with international trade disputes continuing and industry overcapacity, primarily in China, persisting. Pricing across the value chain has fallen sharply to historic lows during 2015 although wafer and cell prices have stabilised recently. Profitability remains elusive for wafer and cell manufacturing companies with market prices remaining below the cost of production despite the benefit of lower polysilicon pricing.

Chinese companies have increased their dominant position across the value chain according to figures released by CCID Think Tank, which is part of China's Ministry of Industry and Information Technology (MIIT). In 2014, China-based companies dominated global output and produced 43% of solar-grade polysilicon (132,000MT), 76% of solar-grade crystalline silicon wafers (38GW), 59% of crystalline silicon solar cells (33GW) and 70% of PV modules (35GW).

The Group shipped 104MW of wafers in H1 2015 which was similar to the volume shipped in the same period in the previous year (H1 2014: 99MW) and broadly in line with volume produced during the period. In view of the adverse market pricing the Group continues to limit output to conserve cash while maintaining a production volume consistent with its dual aims of developing a competitive cost position and a sustainable customer base in the shrinking accessible market which exists outside China.

In 2008 the Group secured several agreements to supply wafers to customers at fixed prices, which were very considerably above today's market levels, for periods of up to 7 years. No wafers have been supplied under these long term supply contracts since 2013 as the contracts have either expired, the customers entered insolvency or satisfactory termination agreements have been negotiated. One claim with the administrator of a customer in insolvency remains outstanding and a settlement is expected before the end of 2015.

 

The Group's remaining long term contract customer, which is one the world's leading PV companies, has failed to purchase wafers in line with its obligations. Despite extensive negotiations over the last two years it has not been possible to negotiate mutually agreeable terms which would enable the supply of wafers to be resumed. In view of the absence of any substantive progress a request for arbitration was filed in March 2015 with the International Court of Arbitration of the International Chamber of Commerce.

In common with most PV companies, the Group is burdened with long-term polysilicon purchase agreements which were signed in 2008 and 2010 in order to secure supply of this critical raw material necessary to meet obligations under wafer supply agreements. The contracted polysilicon pricing very considerably exceeds (by a factor of three) current market levels and is incompatible with current wafer prices. The Group has two such purchase contracts and has received good cooperation from both suppliers which has enabled agreement to be reached on adjustment of both pricing and volumes. In the case of the larger contract, the terms continue to be negotiated on a quarterly basis and the contract will expire at the end of 2015. The terms of the smaller contract were formally amended in 2014 and again more recently during this year to fix the pricing at a significantly lower level over the duration of the contract and to spread delivery of the outstanding volume over a longer period (until 2018).

As the Group's wafer production output has been reduced in view of the ongoing cash conservation policy which has been in operation since 2012, the contracted polysilicon purchase volumes are considerably in excess of requirements. Consequently it continues to be necessary to trade the surplus polysilicon at market prices in order to manage inventory and cash flow.

The Group's polysilicon trading activity has recovered significantly during 2015 following the lull in the H2 2014 which resulted in a build up in inventory at the end of 2014. Sales volumes in the year to date already exceed those achieved in the whole of 2014 and have enabled inventory to be stabilised.

 

Financial Review

In the first half of 2015 Group revenues of €33.4 million were 11% higher than during the same period in 2014 (€30.1 million) due to a 4% increase in wafer shipments, trading larger volumes of excess polysilicon than in H1 2014 and positive currency effects. Average spot market prices for wafers and polysilicon in H1 2015 have reduced in US dollar terms by around 25% compared to the same period in last year, but given the devaluation of the euro in 2015 compared to H1 2014 the average sales price reductions in euros are around 5% for the period.

The Group's loss before interest and taxes was €9.2million (H1 2014: €5.8 million). This increased loss was driven by a necessary adjustment to the onerous contract provision to reflect the reduction in spot price of polysilicon since the start of the year, a reduction in other income and increased other expenses which were partly offset by favourable currency movements.

Other income of €0.7 million was €2.6 million less than the €3.3m recognised in H1 2014 when the Group received a settlement from a long term contract customer and also released a provision related to supplier compensations. Other expenses were €0.4 million higher in the first six months of 2015 mainly due to fees in relation to arbitration proceedings with the Group's final long-term contract customer which has failed to purchase wafers in line with its contractual obligations. Offsetting these negative movements are currency gains of €2.1 million compared to losses of €1.7 million in H1 2014.

After including finance costs, which are mainly due to the unwinding of the discount rate used in the calculation of the Group's onerous contract provision, the Group's loss before taxes was €9.5 million (H1 2014: loss of €6.9 million).

The Group's net cash position at the end of the period was €17.1 million, which was €7.5 million lower than the net position of €24.6 million at the start of the year.

 

Risk Factors

The principal risks and uncertainties affecting the business activities of the Group were identified under the heading "Risk management and principal risks" in the Strategic Report on pages 10 to 11 of the 2014 Annual Report, a copy of which is available on the Group's website, www.pvcrystalox.com. In the view of the Board the key risks and uncertainties for the remaining six months of the financial year continue to be those set out in the 2014 Annual Report.

 

Market Drivers

Market analysts IHS are forecasting global solar installations to grow by as much as 30% in 2015 to reach 57 GW. China is expected to be the largest end-market for the third year running and to be the key driver of global demand. China had 33GW of capacity already installed at the end of 2014 and the National Energy Administration (NEA) is targeting a further 17.8GW to be installed in 2015. Three leading industry groups in China have recently urged the government to double the 2020 target for installed capacity to 200GW.

Japan and USA will continue to be the other major markets and are expected to install 10GW and 9GW respectively. The recently announced US Clean Power plan which targets 28% of electricity to be generated from renewable sources by 2030 should provide further stimulus to US PV installations in future years.

Long running trade disputes between China and both the USA and Europe continue to impact global markets.

Following an investigation into alleged unfair trade practices and dumping by Chinese solar firms the EU Commission (EC) introduced a minimum import price (MIP) for Chinese solar modules in December 2013. Under this trade agreement, an MIP of €0.56/W and an import quota of 7GW were imposed for two years until December 2015. However, following widespread allegations of circumvention of the MIP, European PV companies are expected to request formally that the EC carry out an expiration review which would necessitate the MIP being extended into 2016 while the review is carried out.

Earlier, in May 2015, following complaints that Chinese companies were shipping re-labelled solar modules from China to Europe via Malaysia and Taiwan, the EC had initiated an investigation into solar imports of products exported by Chinese suppliers, from those countries.

In July 2015 the US Department of Commerce announced the outcome of its review of anti-dumping (AD) and anti-subsidy (AS) rates on imported Chinese modules. The revision of the duties which were originally imposed in December 2012 delivered mixed results for Chinese suppliers. In most case AD duties were decreased but the impact was largely offset by an increase in AS rates so that the net duties for most major companies were around 30%. The review also covers products from Taiwan in an effort to prevent Chinese companies from circumventing duties. Previously duties were only imposed on cells, so Chinese firms were able to avoid the 2012 duties by importing modules with Taiwanese cells.

 

Outlook

The adverse market conditions which have existed since 2011 are expected to continue in the short term and the recent devaluation of the Chinese currency is likely to intensify pressure on pricing. In view of the challenging environment and mindful of the need to protect shareholder value, the Board plans to complete a strategic review of the business before the end of the year. The review will take account of the Group's cash position and production cost structure, industry overcapacity and the prospects for rational pricing returning to the market.

 

John Sleeman

Chairman

 

Dr Iain Dorrity

Chief Executive Officer

26 August 2015

 

Consolidated statement of comprehensive income

for the six months ended 30 June 2015

 

Notes

Six months ended

30 June 2015

€'000

Six months ended

30 June 2014

€'000

Year ended

31 December 2014

€'000

Revenues

4

33,421

30,087

53,333

Cost of materials and services

9

(38,925)

(31,337)

(65,694)

Personnel expenses

(3,982)

(4,046)

(6,620)

Depreciation and impairment of property, plant and equipment and amortisation of intangible assets

(164)

(157)

(337)

Other income

652

3,274

12,132

Other expenses

(2,317)

(1,924)

(4,163)

Currency gains/(losses)

2,135

(1,671)

9,043

Loss before interest and taxes ("EBIT")

(9,180)

(5,774)

(2,306)

Finance income

25

27

106

Finance cost

(352)

(1,187)

(2,450)

Loss before taxes ("EBT")

(9,507)

(6,934)

(4,650)

Income taxes

6

3

(3)

(2)

Loss attributable to owners of the parent

(9,504)

(6,937)

(4,652)

Other comprehensive income

 

 

Currency translation adjustment

4,257

1,960

2,498

Total comprehensive loss

 

 

Attributable to owners of the parent

(5,247)

(4,977)

(2,154)

 

Basic and diluted loss per share in Euro cents

 

 

 

From loss for the period/year

7

(6.1)

(4.4)

(3.0)

 

The accompanying notes form an integral part of these financial statements.

 

Consolidated balance sheet

as at 30 June 2015

 

 

Notes

As at

30 June 2015

€'000

As at

30 June 2014

€'000

As at

31 December 2014

€'000

Intangible assets

34

47

38

Property, plant and equipment

8

2,354

2,385

2,355

Pension surplus

-

108

-

Other long-term assets

5,730

11,246

5,425

Total non-current assets

 

8,118

13,786

7,818

Cash and cash equivalents

17,051

35,396

24,592

Trade accounts receivable

4,238

7,663

5,341

Inventories

 

27,962

16,966

28,630

Prepaid expenses and other assets

6,762

10,473

12,380

Current tax assets

 

8

12

16

Total current assets

 

56,021

70,510

70,959

Total assets

 

64,139

84,296

78,777

Loans payable

-

-

-

Trade accounts payable

1,373

1,099

1,762

Deferred revenue

3,254

3,316

3,235

Accrued expenses

1,208

2,226

1,564

Provisions

9

5,542

14,699

14,577

Deferred grants and subsidies

90

135

111

Current tax liabilities

-

199

156

Other current liabilities

 

92

44

72

Total current liabilities

 

11,559

21,718

21,477

Accrued expenses

123

109

111

Provisions

9

1,929

8,732

1,019

Other non-current liabilities

 

205

43

236

Total non-current liabilities

 

2,257

8,884

1,366

Share capital

12,332

12,332

12,332

Share premium

50,511

50,511

50,511

Other reserves

25,096

25,096

25,096

Shares held by the EBT

5

(679)

(7,211)

(679)

Share-based payment reserve

377

810

741

Reverse acquisition reserve

(3,601)

(3,601)

(3,601)

Accumulated losses

(17,135)

(2,870)

(7,631)

Currency translation reserve

 

(16,578)

(21,373)

(20,835)

Total equity

 

50,323

53,694

55,934

Total liabilities and equity

64,139

84,296

78,777

 

The accompanying notes form an integral part of these financial statements.

 

Consolidated statement of changes in equity

for the six months ended 30 June 2015

 

 

Share

capital

€'000

Share

premium

€'000

Other

reserves

€'000

Shares

held by

the EBT

€'000

Share-

based

payment

reserve

€'000

Reverse

acquisition

reserve

€'000

Retained

earnings/

(accumulated losses)

€'000

Currency

translation

reserve

€'000

Total

equity

€'000

As at 1 January 2015

12,332

50,511

25,096

(679)

741

(3,601)

(7,631)

(20,835)

55,934

Share-based payment charge

-

-

-

-

191

-

-

-

191

Award of shares

-

-

-

-

(555)

-

-

-

(555)

Transactions with owners

-

-

-

-

(364)

-

-

-

(364)

Loss for the period

-

-

-

-

-

-

(9,504)

-

(9,504)

Currency translation adjustment

-

-

-

-

-

-

-

4,257

4,257

Total comprehensive loss

-

-

-

-

-

-

(9,504)

4,257

(5,247)

As at 30 June 2015

12,332

50,511

25,096

(679)

377

(3,601)

(17,135)

(16,578)

50,323

 

As at 1 January 2014

 12,332

 50,511

 25,096

(7,610)

 922

(3,601)

 4,067

(23,333)

58,384

Share-based payment charge

-

-

-

-

56

-

-

-

56

Award of shares

-

-

-

399

(168)

-

-

-

231

Transactions with owners

-

-

-

399

(112)

-

-

-

287

Loss for the period

-

-

-

-

-

-

(6,937)

-

(6,937)

Currency translation adjustment

-

-

-

-

-

-

-

1,960

1,960

Total comprehensive loss

-

-

-

-

-

-

(6,937)

1,960

(4,977)

As at 30 June 2014

12,332

50,511

25,096

(7,211)

810

(3,601)

(2,870)

(21,373)

53,694

  

Consolidated cash flow statement

for the six months ended 30 June 2015

 

 

Notes

Six months ended

30 June 2015

€'000

Six months ended

30 June 2014

€'000

Year ended

31 December 2014

€'000

Loss before taxes

(9,507)

(6,934)

(4,650)

Adjustments for:

 

Net interest expense

327

1,160

2,344

Depreciation and amortisation

164

157

337

Change in pension accruals and share based payment charge

(353)

287

-

Decrease in provisions

(9,847)

(5,345)

(14,761)

Gain from the disposal of property, plant and equipment

-

(2)

(2)

Losses in foreign currency exchange

-

-

156

Change in deferred grants and subsidies

(21)

(24)

(48)

(19,237)

(10,701)

(16,624)

Changes in working capital

 

Decrease/(increase) in inventories

3,298

(3,370)

(14,847)

Decrease in accounts receivables

2,918

6,749

9,074

Decrease in accounts payables and deferred revenue

(2,380)

(2,804)

(2,926)

Decrease in other assets

6,965

5,342

9,576

Decrease/(increase) in other liabilities

18

(9)

22

(8,418)

(4,793)

(15,725)

Income taxes (paid)/received

(145)

53

7

Interest received

25

27

44

Net cash flows used in operating activities

(8,538)

(4,713)

(15,674)

Cash flow from investing activities

 

Proceeds from sale of property, plant and equipment

-

2

2

Proceeds from investment grants and subsidies

-

7

7

Payments to acquire property, plant and equipment and intangibles

 

(11)

(136)

(251)

Net cash flows used in investing activities

(11)

(127)

(242)

Cash flow from financing activities

 

Repayment of bank and other borrowings

-

(712)

(712)

Interest paid

-

(1)

(1)

Net cash flows used in financing activities

-

(713)

(713)

Cash generated from operations

 

(8,549)

(5,553)

(16,629)

Effects of foreign exchange rate changes on cash and cash equivalents

 

1,008

1,049

1,321

Cash and equivalents at beginning of the period

24,592

39,900

39,900

Cash and equivalents at end of the period

17,051

35,396

24,592

 

The accompanying notes form an integral part of these financial statements.

 

Notes to the consolidated interim financial statements

for the six months ended 30 June 2015

 

1. Basis of preparation

These condensed consolidated interim financial statements are for the six months ended 30 June 2015. They have been prepared in accordance with International Accounting Standard ("IAS") 34, 'Interim Financial Reporting'. They do not include all the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2014.

The statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the financial statements for the year ended 31 December 2014.

The nature of the Group's operation means that it can vary production levels to match market requirements. As part of the cash conservation measures and the associated planning assumptions, production output currently remains reduced to match expected demand. In line with the Group's strategy of retaining flexibility in production levels, production can be brought back on stream when market conditions allow.

On 30 June 2015 there was a net cash balance of €17.1 million, including funds held by an employee benefit trust.

As part of its normal business practice, the Group regularly prepares both annual and longer-term plans which are based on the directors' expectations concerning key assumptions. The assumptions around contracted sales volumes and prices and contracted purchase volumes and prices are based on management's expectations. As a result of these modelling assumptions the base plans indicate that the Group will be able to operate within its net cash reserves for the foreseeable future.

Therefore, whilst any consideration of future matters involves making a judgement at a particular point in time about future events that are inherently uncertain, the directors, after careful consideration and after making appropriate enquiries, are of the opinion that the Group has adequate resources to continue in operational existence for at least twelve months from the date of approval of the financial statements. Thus the Group continues to adopt the going concern basis of accounting in preparing the interim financial statements.

Were the Group not to adopt the going concern basis at any point, all assets and liabilities would be reclassified as short term and valued on a break-up basis.

 

2. Basis of consolidation

The Group financial statements consolidate those of the parent company and its subsidiary undertakings drawn up to 30 June 2015. Subsidiaries are entities over which the Group has the power to control the financial and operating policies so as to obtain benefits from its activities. The Group obtains and exercises control through voting rights. Consolidation is conducted by eliminating the investment in the subsidiary with the parent's share of the net equity of the subsidiary.

The results of any subsidiary sold or acquired are included in the Consolidated Statement of Comprehensive Income up to, or from, the date control passes.

 

3. Functional and presentational currency

Items included in the financial statements of each of the Group's entities are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). The functional currency of the parent company is Sterling. The financial information has been presented in Euros, which is the Group's presentational currency. The Euro has been selected as the Group's presentational currency as this is the currency used in its significant contracts. The financial statements are presented in round thousands..

 

4. Segment reporting

The chief operating decision-maker, who is responsible for allocating resources and assessing performance, has been identified as the executive Board. The Group is organised around the production and supply of one product, multicrystalline silicon wafers. Accordingly, the Board reviews the performance of the Group as a whole and there is only one operating segment. Disclosure of reportable segments under IFRS 8 is therefore not made.

Geographical information for the six months ended 30 June 2015

 

Japan

€'000

Taiwan

€'000

Canada

€'000

Germany

€'000

United

Kingdom

€'000

Rest of

Europe

€'000

Rest of

World

€'000

Group

€'000

Revenues

By entity's country of domicile

185

-

-

2,035

31,201

-

-

33,421

By country from which derived

185

17,146

9,760

39

-

5,423

868

33,421

Non-current assets*

By entity's country of domicile

231

-

-

867

7,019

-

-

8,117

* Excludes financial instruments, deferred tax assets and post-employment benefit assets.

Two customers accounted for more than 10% of Group revenue each and sales to these customers are as follows (figures in €'000):

1. 14,388 (Taiwan);

2. 9,760 (Canada).

No sales to Korea were made in the period.

Geographical information for the six months ended 30 June 2014

 

Japan

€'000

Taiwan

€'000

Korea

€'000

Germany

€'000

United

Kingdom

€'000

Rest of

Europe

€'000

Rest of

World

€'000

Group

€'000

Revenues

 

 

 

 

 

 

 

 

By entity's country of domicile

124

-

-

2,139

27,824

-

-

30,087

By country from which derived

149

18,881

4,299

62

-

6,108

588

30,087

Non-current assets*

 

 

 

 

 

 

 

 

By entity's country of domicile

218

-

-

1,064

12,396

-

-

13,678

* Excludes financial instruments, deferred tax assets and post-employment benefit assets.

Four customers accounted for more than 10% of Group revenue each and sales to these customers are as follows (figures in €'000):

1. 8,590 (Taiwan);

2. 5,421 (Taiwan);

3. 4,244 (Korea); and

4. 3,820 (Taiwan).

Sales to Canada of €352k are included in Rest of World.

 

5. Employee Benefit Trust

As at 30 June 2015 the Employee Benefit Trust ("EBT") held 3,853,910 shares (2.4%) of the issued share capital in the Company. It holds these shares in trust for the benefit of employees.

In December 2014 the Directors agreed to write down the value of the shares held by the EBT to the market value at 31 December 2014. The share price was 13 pence per ordinary share of 5.2 pence each. This adjustment alters the value of the shares held by the EBT and reduces retained earnings by €6.868 million

 

6. Income tax

The average taxation rate shown in the Consolidated Statement of Comprehensive Income is nil% (H1 2014: nil%).

The anticipated long-term average tax rate for the Group, normalised on the basis that the Group returns to profitability, is approximately 20%.

 

7. Earnings per share

Net earnings per share is computed by dividing the net (loss)/profit for the period attributable to ordinary shareholders of €9.5 million (H1 2014: loss of €6.9 million) by the weighted average number of ordinary shares outstanding during the year.

Diluted net earnings per share is computed by dividing the (loss)/profit for the year by the weighted average number of ordinary shares outstanding and, when dilutive, adjusted for the effect of all potentially dilutive shares, including share options. A s the Group is currently loss making, the diluted loss per share is equal to the basic loss per share.

The calculation of the weighted average number of ordinary shares is set out below:

 

Six months

ended

30 June 2015

Six months

ended

30 June 2014

Number of shares

160,278,975

160,725,335

Average number of shares held by the EBT in the period

(3,853,910)

(3,990,051)

Weighted average number of shares for basic earnings per share calculation

156,425,065

156,735,284

Shares granted but not vested

4,017,108

2,127,348

Weighted average number of shares for fully diluted earnings per share calculation

160,442,173

158,862,632

 

8. Property, plant and equipment

Additions to property, plant and equipment in the six months ended 30 June 2015 were less than €0.1 million (H1 2014: less than €0.1 million).

 

9. Onerous contract provision

Included in provisions is an onerous contract provision of €7.4 million. The onerous contract provision is an allowance for the loss arising on the difference between raw material costs under these contracts and the anticipated selling price of the Group's end product. Following a review of all the latest market information and a review of the inputs to the onerous contract provision, the following movements are reflected in the financial statements.

 

As at

30 June 2015

€'000

As at

30 June 2014

€'000

As at

31 December 2014

 €'000

Onerous contract provision brought forward

15,542

26,526

26,526

Exchange differences

(1,920)

1,373

(8,902)

Unwinding of discounting factor

332

1,185

2,390

Utilised

(11,712)

(6,412)

(12,634)

Additional provision/(release) charged/(credited) to the income statement

5,185

726

8,162

Onerous contract provision carried forward

7,427

23,398

15,542

 

10. Changes in contingent assets and liabilities

There were no changes in contingent assets and liabilities.

 

11. Related party disclosures

The Group defines related parties as the senior executives of the Group and also companies that these persons could have a material influence on as related parties as well as other Group companies. During the reporting period, none of the shareholders had control over or a material influence in the parent company.

Transactions between the Company and its subsidiaries have been eliminated on.

 

12. Post balance sheet events

There are no significant post balance sheet events.

 

13. Approval of interim financial statements

The unaudited consolidated interim financial statements for the six months ended 30 June 2015 were approved by the Board of Directors on 26 August 2015.

The financial information for the year ended 31 December 2014 set out in this Interim Report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2014 have been filed with the Registrar of Companies. The Auditors' Report on those financial statements was unqualified and did not contain statements under Section 498(2) or Section 498(3) of the Companies Act 2006.

 

Statement of directors' responsibilities

to the members of PV Crystalox Solar PLC

 

The directors confirm that this condensed set of financial statements has been prepared in accordance with IAS 34, 'Interim Financial Reporting' as adopted by the European Union and that this Interim Report includes a fair review of the information required by the Disclosure and Transparency Rules of the Financial Services Authority, paragraphs DTR 4.2.7 and DTR 4.2.8.

The directors of PV Crystalox Solar PLC are listed at the end of this Interim Report and their biographies are included in the PV Crystalox Solar Annual Report for the year ended 31 December 2014.

By order of the Board

 

Matthew Wethey

Chief Financial Officer and Group Secretary

26 August 2015

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEUFMMFISEDA
Date   Source Headline
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:03 amRNSPrice Monitoring Extension
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20202:15 pmRNSHolding(s) in Company
22nd Sep 202012:15 pmRNSDirector/PDMR Shareholding
18th Sep 20202:45 pmRNSHolding(s) in Company
11th Sep 20207:00 amRNSResult of Tender Offer
9th Sep 202012:05 pmRNSResult of Meeting
27th Aug 20207:00 amRNSHalf-year Report
16th Jul 20207:00 amRNSTender Offer, Notice of GM and Cancellation
1st Jul 20207:00 amRNSChange of CFO and Group Secretary
29th Jun 20207:00 amRNSSettlement payment received and tender offer
23rd Jun 20202:00 pmRNSResult of AGM
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSFinal Results
2nd Jan 20203:29 pmRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSHalf-year Report
1st Jul 20199:36 amRNSResult of AGM
14th Jun 20194:40 pmRNSSecond Price Monitoring Extn
14th Jun 20194:35 pmRNSPrice Monitoring Extension
6th Jun 201911:24 amRNSShare Capital Consolidation
5th Jun 20192:25 pmRNSShare Capital Consolidation & Amended Timetable
16th May 20199:09 amRNSHolding(s) in Company
15th May 201912:18 pmRNSResult of General Meeting
18th Apr 20197:00 amRNSNotice of GM
12th Apr 20197:00 amRNSHolding(s) in Company
10th Apr 20197:00 amRNSHolding(s) in Company
22nd Mar 20194:09 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSFinal Results
14th Mar 20194:33 pmRNSHolding(s) in Company
1st Feb 201910:50 amRNSUpdate on Group Strategy
4th Dec 20183:26 pmRNSHolding(s) in Company
30th Nov 20189:51 amRNSReceipt of Final Payment
14th Sep 20187:00 amRNSHalf-year Report
17th Aug 20187:00 amRNSSettlement Agreement
18th May 201811:03 amRNSAGM Results
9th May 20187:00 amRNSReceipt of part payment of arbitration award
15th Mar 20187:00 amRNSPreliminary Results
13th Mar 201811:19 amRNSNotice of Results
8th Nov 201710:58 amRNSArbitration Award
21st Sep 201710:17 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSDelay on arbitration judgement
24th Aug 20177:00 amRNSHalf-year Report
13th Jul 201712:01 pmRNSClosure of UK manufacturing operations
19th May 20179:51 amRNSHolding(s) in Company
19th May 20179:44 amRNSAGM Results
23rd Mar 20177:00 amRNSPreliminary Results 2017
26th Oct 20167:00 amRNSUpdate on arbitration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.